Drug Profile
Research programme: inflammatory and infectious disease therapies - Implicit Bioscience
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Implicit Bioscience
- Class Anti-infectives; Anti-inflammatories
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Infections; Inflammation
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Infections(In infants) in Australia
- 28 Aug 2020 No recent reports of development identified for preclinical development in Inflammation(In infants) in Australia